Golden
Advent Venture Partners

Advent Venture Partners

Advent Venture Partners is one of Europe's growth and venture capital investors in tech and life sciences businesses.

Advent Venture Partners is a venture capital and private equity firm specializing in startups, seed, early, mid-stage, late venture, emerging growth investments, later stage, buyout, and growth capital investments.

History

Advent Venture Partners is a firm investing in tech and life sciences businesses. It is based in London and was founded in 1981.

Advent Venture Partners is a privately held venture capital & private equity company. It operates in the following areas: venture capital, growth capital, technology, digital media, e-commerce, internet, mobile, software, cleantech, consumer, life sciences, biotech, biopharma, medical devices, platform technologies, and financing.

Services

The firm prefers to invest in innovative life sciences, telecommunication services, utilities, and information technology sectors. In innovative life sciences, it prefers to invest in diagnostics, biopharmaceuticals, medical device research and development, pharmaceuticals, platform technologies, and companies seeking to develop breakthrough products for unmet medical needs with a special focus on new drug discovery- small molecules, biologics and new modalities including med tech, enabling technologies and vaccines. In information technology, the firm focuses on communications, clean technology, digital media & Internet, e-commerce, semiconductor & components, and software & services.

Investments

Advent Venture Partners has made 78 investments as of February 2019.It has had 27 exits. The most notable exits include Farfetch, WorldStores, and Dailymotion.

Advent Venture Partners has raised a total of $492.6M across 3 funds. The Advent Life Sciences Fund II LP was announced on Sep 10, 2014, and raised a total of $146.3M.

It focuses on investments in the United Kingdom, Western European, Europe, and the United States. Within Western European markets, it prefers to invest in Andorra, Portugal, and Spain. Within Utilities, it prefers to invest in Alternate energy Resources, Independent power producers, and energy traders.

The firm typically invests between £5 million ($9.46 million) and £15 million ($29 million) in its portfolio companies. Its technology investments focus on startups with sales above €4 million ($5.7 million) and which are often seeking external capital for the first time. For information technology investments, the firm prefers to take small minority positions to full buyouts and a majority stake in a portfolio company. It seeks to take a board seat in its portfolio companies.

Timeline

WorldStores

Series D - WorldStores

£25M

Advent Life Sciences Fund II LP

$146.3M

Farfetch

Series D - Farfetch

$66M

Versartis

Series D - Versartis

$20M

Acutus Medical

Series B - Acutus Medical

$28M

Versartis

Series C - Versartis

$12.5M

WorldStores

Series C - WorldStores

$15.2M

Farfetch

Series C - Farfetch

$20M

Versartis

Series C - Versartis

$25M

NeRRe Therapeutics

Series A - NeRRe Therapeutics

$18.4M

F2G

Venture Round - F2G

$30M

Life sciences fund I

$120M

Advent Private Equity Fund IV

£128M

People

Name
Role
Related Golden topics

Alain Huriez

Alan E. Walts

Venture Partner

Andrew J Wood

Venture Partner

Dale Pfost

General Partner

Don Drakeman

Venture Partner

Ian J. Nicholson

Operating Partner

John Rex

Operating Partner

Jon Moore

Operating Partner

Kaasim Mahmood

General Partner

Mary Kerr

Operating Partner

Naseem Amin

Venture Partner

Raj Parekh

General Partner

Roy Lobb

Venture Partner

Shahzad Malik

General Partner

Simon Kerry

Operating Partner

Steve Butcher

Operating Partner

Further reading

Title
Author
Link
Type

A French VC Shows off a New Fund -- and Growing Interest in Europe

Web

Advent gears up for launch of third life sciences fund | Unquote

Web

Advent Venture Partners Announces Final Close of First Life Sciences Venture Fund | FierceBiotech

Web

Advent Venture Partners Start Life Science Fund with $118M

Web

Fashion Marketplace Farfetch Raises $86M Led By DST At A $1B Valuation

Web

Felix Capital At The Intersection Of Creativity And Tech - Informilo

Web

Fizzback bags $5m from Advent Venture Partners - Econsultancy

Web

Fred Destin of Accel Partners on What's Changing (Fast) in Europe

Web

Future Of Cancer Treatment: Immunotherapy Startups Take Lion's Share of Oncology Deals

Web

Investment in Farfetch.com by Advent Venture Partners

Web

Markham Rae Appoints Kah Chye Tan and Sir David Cooksey to Markham Rae Trade Capital Partners Advisory Board

Markham Rae (UK) Ltd.

Web

Petroni Vineyards Grows from Humble Roots to Become the Ultimate Sonoma Wine Destination

Web

The International Unicorn Club: 107 Private Companies Outside The US Valued At $1B+

Web

With Felix Capital, Frederic Court brings Silicon Valley-style investment to Europe

Web

Documentaries, videos and podcasts

Title
Date
Link

Frederic Court Interview - video dailymotion

RANKED: The 22 biggest European venture capital firms in 2016

What Big Ideas are VC's Betting on in Digital Advertising - video dailymotion

Companies

Company
CEO
Location
Products/Services

Aleta Biotherapeutics

Algeta

Alpha Anomeric

Artax Biopharma

Avila

Axonics Modulation Technologies

Biocartis

Calcico Therapeutics

Capella Biosciences

CardiacAssist

CardioKine

Cellnovo

CN Creative

EUSA Pharma

F2G

GMP-Orphan

SHOW ALL (41)

References